A detailed history of Pictet Asset Management Sa transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Pictet Asset Management Sa holds 5,286,536 shares of BCRX stock, worth $40 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
5,286,536
Previous 5,618,372 5.91%
Holding current value
$40 Million
Previous $46.9 Million 20.57%
% of portfolio
0.04%
Previous 0.06%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$6.96 - $8.81 $2.31 Million - $2.92 Million
-331,836 Reduced 5.91%
5,286,536 $37.2 Million
Q1 2023

May 10, 2023

BUY
$7.94 - $11.84 $2.64 Million - $3.94 Million
333,024 Added 6.3%
5,618,372 $46.9 Million
Q4 2022

Feb 13, 2023

BUY
$10.5 - $14.2 $4.95 Million - $6.7 Million
471,576 Added 9.8%
5,285,348 $60.7 Million
Q3 2022

Nov 14, 2022

SELL
$10.79 - $14.81 $13.3 Million - $18.3 Million
-1,233,189 Reduced 20.39%
4,813,772 $60.7 Million
Q2 2022

Aug 09, 2022

BUY
$7.89 - $17.88 $7.42 Million - $16.8 Million
940,058 Added 18.41%
6,046,961 $64 Million
Q1 2022

May 13, 2022

BUY
$11.56 - $19.76 $596,946 - $1.02 Million
51,639 Added 1.02%
5,106,903 $83 Million
Q4 2021

Feb 10, 2022

BUY
$11.18 - $15.46 $56.4 Million - $78 Million
5,043,299 Added 42150.43%
5,055,264 $70 Million
Q3 2021

Nov 12, 2021

BUY
$14.21 - $17.65 $170,022 - $211,182
11,965 New
11,965 $172,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.41B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.